Oil prices rise from over 1-mth low with Russia crude buyer sanctions in focus
Investing.com - Orthofix reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Orthofix announced earnings per share of $0.09 on revenue of $114.00. Analysts polled by Investing.com EPS of $0.06 on revenue of $120.68M.
Orthofix 's are down 9% and is trading at $14.87 , still down 61.70% from its 52 week high of $38.83 set on Thursday, November 4, 2021.
Orthofix follows other major Healthcare sector earnings this month
Orthofix's report follows an earnings beat by Exelixis on Tuesday, August 9, 2022, who reported EPS of $0.22 on revenue of $419.43M, EPS of $0.203 on revenue of $391.03M.
Neogen had missed expectations on Tuesday, September 27, 2022 with first quarter EPS of $0.05 on revenue of $132.35M, for EPS of $0.105 on revenue of $135.75M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar